Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to -$5.8 million.

  • Xtant Medical Holdings' Cash from Financing Activities fell 20859.99% to -$5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.9 million, marking a year-over-year decrease of 13989.1%. This contributed to the annual value of $16.1 million for FY2024, which is 1837.39% down from last year.
  • Latest data reveals that Xtant Medical Holdings reported Cash from Financing Activities of -$5.8 million as of Q3 2025, which was down 20859.99% from $662000.0 recorded in Q2 2025.
  • Xtant Medical Holdings' 5-year Cash from Financing Activities high stood at $18.1 million for Q1 2021, and its period low was -$5.8 million during Q3 2025.
  • For the 5-year period, Xtant Medical Holdings' Cash from Financing Activities averaged around $3.0 million, with its median value being $662000.0 (2025).
  • Examining YoY changes over the last 5 years, Xtant Medical Holdings' Cash from Financing Activities showed a top increase of 5331176.47% in 2021 and a maximum decrease of 151500.0% in 2021.
  • Over the past 5 years, Xtant Medical Holdings' Cash from Financing Activities (Quarter) stood at -$55000.0 in 2021, then skyrocketed by 10307.27% to $5.6 million in 2022, then crashed by 94.21% to $325000.0 in 2023, then plummeted by 362.77% to -$854000.0 in 2024, then plummeted by 575.76% to -$5.8 million in 2025.
  • Its Cash from Financing Activities was -$5.8 million in Q3 2025, compared to $662000.0 in Q2 2025 and -$919000.0 in Q1 2025.